Le Lézard
Classified in: Business
Subjects: SHAREHOLDER RIGHTS PLANS, MISCELLANEOUS, MISCELLANEOUS

Transaction in Own Shares


Transaction in Own Shares

6 February, 2024

? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?

Shell plc (the ?Company') announces that on 6 February 2024 it purchased the following number of Shares for cancellation.

Aggregated information on Shares purchased according to trading venue:

Date of purchaseNumber of Shares purchasedHighest price paid

 
Lowest price paid

 
Volume weighted average price paid per shareVenueCurrency
06/02/2024945,000 £25.0450£24.8150£24.9126LSEGBP
06/02/2024- £0.0000£0.0000£0.0000Chi-X (CXE)GBP
06/02/2024- £0.0000£0.0000£0.0000BATS (BXE)GBP
06/02/2024940,000 ?29.5650?29.3800?29.4745XAMSEUR
06/02/2024- ?0.0000?0.0000?0.0000CBOE DXEEUR
06/02/2024- ?0.0000?0.0000?0.0000TQEXEUR

These share purchases form part of the on- and off-market limbs of the Company's existing share buy-back programme previously announced on 1 February 2024.

In respect of this programme, Citigroup Global Markets Limited will make trading decisions in relation to the securities independently of the Company for a period from 1 February 2024 up to and including 26 April 2024.

The on-market limb will be effected within certain pre-set parameters and in accordance with the Company's general authority to repurchase shares on-market. The off-market limb will be effected in accordance with the Company's general authority to repurchase shares off-market pursuant to the off-market buyback contract approved by its shareholders and the pre-set parameters set out therein. The programme will be conducted in accordance with Chapter 12 of the Listing Rules and Article 5 of the Market Abuse Regulation 596/2014/EU dealing with buy-back programmes ("EU MAR") and EU MAR as "onshored" into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020) through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time ("UK MAR") and the Commission Delegated Regulation (EU) 2016/1052 (the "EU MAR Delegated Regulation") and the EU MAR Delegated Regulation as "onshored" into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020) through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time.

In accordance with EU MAR and UK MAR, a breakdown of the individual trades made by Citigroup Global Markets Limited on behalf of the Company as a part of the buy-back programme is detailed below.

Enquiries

Media International: +44 (0) 207 934 5550

Media Americas: +1 832 337 4335

LEI number of Shell plc: 21380068P1DRHMJ8KU70

Classification: Acquisition or disposal of the issuer's own shares

Attachment



These press releases may also interest you

at 16:38
NASA has selected FedSync-BFS, LLC of Alexandria, Virginia, to provide administrative services for multiple NASA centers. The...

at 16:36
Cambridge, a leading independent financial solutions firm serving 3,800 financial professionals across the country, won multiple awards at the 2024 ThinkAdvisor Luminaries Awards Dinner and Gala held in Las Vegas, Nevada earlier this week. The...

at 16:35
The Board of Directors (the "Board") of The China Fund, Inc. (the "Fund") has declared a distribution in the amount of $0.1497 per share. The distribution is comprised entirely of ordinary income. The dividend will be payable on January 10, 2025, to...

at 16:35
The China Fund, Inc. (the "Fund") announced today that the Fund's annual stockholder meeting (the "Meeting") will be scheduled for Thursday, March 13, 2025, via a virtual forum at 11:00 a.m. ET.  Stockholders of record as of January 15, 2025 will be...

at 16:30
Edesa Biotech, Inc. , a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the fiscal year ended September 30, 2024 and provided an update...

at 16:30
Flagstar Financial, Inc. (the "Company") today announced the appointment of Brian Callanan, Senior Managing Director and General Counsel at Liberty Strategic Capital ("Liberty"), to its Board of Directors, effective December 16, 2024....



News published on and distributed by: